NCT02841241View on ClinicalTrials.gov

Esmolol Infusion for Patients With Septic Shock and Persistent Tachycardia

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Septic Shock
Interventions
DRUG

Esmolol

Esmolol infusion

Trial Locations (1)

84143

Intermountain Medical Center and Intermountain Clinics, Murray

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Intermountain Health Care, Inc.

OTHER

NCT02841241 - Esmolol Infusion for Patients With Septic Shock and Persistent Tachycardia | Biotech Hunter | Biotech Hunter